Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality
- 1 December 1986
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 865 (3) , 267-279
- https://doi.org/10.1016/0304-419x(86)90017-x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Functional studies on the precursors of human lymphokine-activated killer cellsCellular Immunology, 1985
- THE DIFFERENTIAL INHIBITORY EFFECTS EXERTED BY CYCLOSPORINE AND HYDROCORTISONE ON THE ACTIVATION OF HUMAN CYTOTOXIC LYMPHOCYTES BY RECOMBINANT INTERLEUKIN-2 VERSUS ALLOSPECIFIC CTLTransplantation, 1985
- Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancerCancer, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.The Journal of Experimental Medicine, 1984
- In vitro growth of cytotoxic human lymphocytesCellular Immunology, 1982
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- In vitro „education”︁ on autologous human sarcoma generates non‐specific killer cellsInternational Journal of Cancer, 1975